publication venue for
- Editorial: Community series - liver fibrosis and MAFLD: from molecular aspects to novel pharmacological strategies, volume II 2024
- Chemo-radiotherapy with 177Lu-PLGA(RGF)-CXCR4L for the targeted treatment of colorectal cancer 2023
- Editorial: Pulmonary embolism¿New diagnostic and therapeutic strategies 2023
- Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study 2023
- Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies. 9. 2022
- Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection. 8. 2022
- MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis. 8. 2022
- An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease. 8. 2022
- Clinical Risk Factors for Mortality Among Critically Ill Mexican Patients With COVID-19. 8. 2021
- Ex vivo manufactured neutrophils for treatment of neutropenia-A process economic evaluation. 6. 2019